OverviewSuggest Edit

Quest Diagnostics is the world's leading provider of diagnostic testing, information, and services that patients and doctors need to make better healthcare decisions. The Company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, interpretive consultation through its extensive medical and scientific staff, cancer diagnostics, and anatomic pathology services.

Quest Diagnostics's wide range of products and services benefit patients, healthcare providers, and pharmaceutical medical device companies, life insurance companies, and employers.

TypePublic
Founded1967
HQMadison, US
Websitequestdiagnostics.com
Employee Ratings3.3

Latest Updates

Employees (est.) (Dec 2018)46,000(+3%)
Job Openings2,528
Revenue (FY, 2018)$7.5 B(-2%)
Share Price (Mar 2019)$88.7

Key People/Management at Quest Diagnostics

Stephen H. Rusckowski

Stephen H. Rusckowski

Chairman, President and Chief Executive Officer

Quest Diagnostics Office Locations

Quest Diagnostics has offices in Madison, Secaucus, Vega Alta, Barceloneta and in 6 other locations
Madison, US (HQ)
Giralda Farms
Secaucus, US
500 Plaza Dr
Barceloneta, PR
PR-2
Bayamón, PR
Av. Main
Caguas, PR
5 Calle Padial
Caguas, PR
5 Av. Luis Muñoz Marín
Show all (12)
Report incorrect company information

Quest Diagnostics Financials and Metrics

Quest Diagnostics Revenue

Embed Graph
View revenue for all periods
Quest Diagnostics's revenue was reported to be $7.53 b in FY, 2018
USD

Revenue (FY, 2018)

7.5b

Gross profit (FY, 2018)

2.6b

Gross profit margin (FY, 2018), %

34.6%

Net income (FY, 2018)

788.0m

EBIT (FY, 2018)

1.1b

Market capitalization (18-Mar-2019)

11.9b

Closing stock price (18-Mar-2019)

88.7

Cash (31-Dec-2018)

135.0m

EV

15.7b
Quest Diagnostics's current market capitalization is $11.9 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

7.1b7.4b7.5b7.5b7.7b7.5b

Revenue growth, %

4%1%0%3%

Cost of goods sold

4.3b4.6b4.7b4.6b4.7b4.9b

Gross profit

2.8b2.8b2.8b2.9b3.0b2.6b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

1.8b1.7b1.9b1.9b1.8b1.9b1.9b1.9b1.9b1.9b1.9b1.9b1.9b1.9b3.8b1.9b

Cost of goods sold

1.1b1.1b1.2b1.2b1.2b1.2b1.2b1.1b1.2b1.2b1.2b1.2b1.2b1.2b2.5b1.2b

Gross profit

698.6m645.0m728.0m726.0m676.0m743.0m718.0m719.0m751.0m728.0m734.0m773.0m741.0m658.0m1.3b667.0m

Gross profit Margin, %

39%37%38%38%37%39%38%39%39%39%39%40%38%35%35%35%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

187.0m192.0m133.0m359.0m137.0m135.0m

Accounts Receivable

926.0m924.0m

Prepaid Expenses

155.0m150.0m

Inventories

91.0m110.0m84.0m82.0m95.0m99.0m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

158.3m144.0m144.0m170.0m974.0m150.0m123.0m128.0m283.0m406.0m367.0m314.0m350.0m124.0m132.0m263.0m

Inventories

85.2m99.0m109.0m111.0m106.0m109.0m86.0m82.0m80.0m82.0m77.0m83.0m100.0m94.0m91.0m95.0m

Current Assets

1.4b1.5b1.5b1.6b2.4b1.5b1.6b1.5b1.5b1.6b1.6b1.5b1.5b1.4b1.4b1.6b

PP&E

749.4m851.0m884.0m888.0m902.0m906.0m886.0m925.0m937.0m952.0m1.0b1.0b1.1b1.2b1.2b1.2b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

883.0m592.0m753.0m696.0m824.0m788.0m

Depreciation and Amortization

304.0m249.0m270.0m309.0m

Accounts Payable

(21.0m)68.0m(24.0m)56.0m(8.0m)(19.0m)

Cash From Operating Activities

652.0m938.0m821.0m1.1b1.2b1.2b
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

732.1m111.0m253.0m392.0m70.0m199.0m553.0m114.0m324.0m529.0m175.0m382.0m557.0m189.0m422.0m649.0m

Depreciation and Amortization

211.0m75.0m156.0m235.0m78.0m153.0m230.0m62.0m123.0m186.0m62.0m128.0m197.0m74.0m151.0m228.0m

Accounts Payable

(76.8m)(86.0m)(39.0m)20.0m(120.0m)(49.0m)(41.0m)(77.0m)23.0m43.0m(95.0m)(93.0m)(3.0m)(68.0m)(64.0m)51.0m

Cash From Operating Activities

441.6m84.0m364.0m635.0m52.0m327.0m539.0m143.0m464.0m765.0m196.0m490.0m852.0m180.0m503.0m905.0m
USDY, 2018

EV/EBIT

14.2 x

EV/CFO

13.1 x

EV/FCF

19.2 x

Revenue/Employee

165.5k

Financial Leverage

2.1 x
Show all financial metrics

Quest Diagnostics Operating Metrics

FY, 2016

Accounts

250 k

Patents Issued

700

Patents Pending

570

Patient Service Centers

2.20 k
Show all operating metrics

Quest Diagnostics Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
California Laboratory AssociatesOctober 30, 2017
Cleveland HeartLabOctober 18, 2017
Cape Cod Healthcare - BusinessJune 28, 2017
ClearPoint DiagnosticJune 12, 2017
Med fusionJune 12, 2017
PeaceHealth LaboratoriesFebruary 15, 2017

Quest Diagnostics Revenue Breakdown

Embed Graph

Quest Diagnostics revenue breakdown by business segment: 95.6% from Diagnostic Information Services and 4.4% from Other

Report incorrect company information

Quest Diagnostics Online and Social Media Presence

Embed Graph
Report incorrect company information

Quest Diagnostics News and Updates

Quest Diagnostics Prices $500 Million of Senior Notes

SECAUCUS, N.J., March 7, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the pricing of a public offering of $500 million aggregate principal amount of its 4.200% senior notes due 2029 under...

Quest Diagnostics To Speak At The Barclays Global Healthcare Conference

SECAUCUS, N.J., March 7, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Barclays Global Healthcare Conference in Miami. Mark Guinan, Executive Vice President...

RMC and Quest Diagnostics to Deliver High-Value, Innovative Lab Services

SECAUCUS, N.J. and ORANGEBURG, S.C., Feb. 27, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center (RMC) of Orangeburg, S.C., are teaming up to enhance the quality and value of diagnostic services...

Quest Diagnostics Partners With Houston Healthcare to Deliver High-Value, Innovative Laboratory Services

SECAUCUS, N.J. and WARNER ROBINS, Ga., Feb. 20, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Houston Healthcare are teaming up to enhance the quality and value of diagnostic services to patients and their doctors...

Quest Diagnostics Elects Denise Morrison to Board of Directors

SECAUCUS, N.J., Feb. 19, 2019 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected Denise M. Morrison to serve as a director, effective February 18, 2019. Including Ms....

Quest Diagnostics Reports Fourth Quarter And Full Year 2018 Financial Results; Provides Guidance For Full Year 2019

SECAUCUS, N.J., Feb. 14, 2019 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2018. "In 2018 we grew revenues, adjusted...
Show more
Report incorrect company information

Quest Diagnostics Blogs

Quest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology Laboratories

Transaction expands access to diagnostic innovations in clinical and pathology services for patients, physicians and hospitals throughout Missouri and surrounding Midwestern states

Aetna and Ascension Join Five Other Leading Health Care Companies in Blockchain-Driven Effort to Address Health Care Provider Data Issues

Pilot Launched in April under Leadership of Humana, MultiPlan, Optum, Quest Diagnostics and UnitedHealthcare

Quest Diagnostics to Acquire the Laboratory Services Business of Boyce and Bynum Pathology Laboratories, Expanding Diagnostic Innovation in the Midwest

Transaction aims to provide a broader range of clinical and pathology diagnostic services to patients, hospitals and physicians throughout Missouri and surrounding Midwestern states

Quest Diagnostics to accelerate cardiovascular disease biomarker discovery as part of One Brave Idea™ initiative to end coronary heart disease

The power of healthcare data gives rise to novel markers of cardiovascular disease and stroke in the earliest, preventable stages
Show more

Quest Diagnostics Frequently Asked Questions

  • When was Quest Diagnostics founded?

    Quest Diagnostics was founded in 1967.

  • Who are Quest Diagnostics key executives?

    Quest Diagnostics's key executives are Stephen H. Rusckowski.

  • How many employees does Quest Diagnostics have?

    Quest Diagnostics has 46,000 employees.

  • What is Quest Diagnostics revenue?

    Latest Quest Diagnostics annual revenue is $7.5 b.

  • What is Quest Diagnostics revenue per employee?

    Latest Quest Diagnostics revenue per employee is $163.7 k.

  • Who are Quest Diagnostics competitors?

    Competitors of Quest Diagnostics include Laboratory Corporation of America Holdings, Thermo Fisher Scientific and Angle.

  • Where is Quest Diagnostics headquarters?

    Quest Diagnostics headquarters is located at Giralda Farms, Madison.

  • Where are Quest Diagnostics offices?

    Quest Diagnostics has offices in Madison, Secaucus, Vega Alta, Barceloneta and in 6 other locations.

  • How many offices does Quest Diagnostics have?

    Quest Diagnostics has 12 offices.